The following discussion contains forward-looking statements that involve risks
and uncertainties. Our actual results may differ materially from those discussed
in the forward-looking statements as a result of various factors, including
those set forth in Part I, Item 1A, "Risk Factors," of our 2020 Form 10-K and
Part II,   Item 1A  , "Risk Factors" and "Note Regarding Forward-Looking
Statements" included in this report and those discussed in other documents we
file from time to time with the SEC. The following discussion of our financial
condition and results of operations should be read in conjunction with our
unaudited condensed consolidated financial statements and the related notes and
other financial information included in this quarterly report and our audited
consolidated financial statements and notes thereto included in our 2020 10-K.
Our historical results are not necessarily indicative of the results to be
expected for any future periods and our operating results for the three months
ended April 3, 2021 are not necessarily indicative of the results to be expected
for the fiscal year ending December 31, 2021 or for any other interim period or
for any other future year or period.

Overview

Beyond Meat is one of the fastest growing food companies in the United States,
offering a portfolio of revolutionary plant-based meats. We build meat directly
from plants, an innovation that enables consumers to experience the taste,
texture and other sensory attributes of popular animal-based meat products while
enjoying the nutritional and environmental benefits of eating our plant-based
meat products. Our brand commitment, Eat What You Love, represents a strong
belief that there is a better way to feed our future and that the positive
choices we all make, no matter how small, can have a great impact on our
personal health and the health of our planet. By shifting from animal-based meat
to plant-based meat, we can positively impact four growing global issues: human
health, climate change, constraints on natural resources and animal welfare. The
success of our breakthrough innovation model and products has allowed us to
appeal to a broad range of consumers, including those who typically eat
animal-based meats, positioning us to compete directly in the $1.4 trillion
global meat industry.

We sell a range of plant-based products across the three main meat platforms of
beef, pork and poultry. As of April 3, 2021, our products were available at
approximately 118,000 retail and foodservice outlets in more than 80 countries
worldwide, across mainstream grocery, mass merchandiser, club, convenience
store, and natural retailer channels, direct to consumer, and various
food-away-from-home channels, including restaurants, foodservice outlets and
schools.
Our primary production facilities are located in Columbia, Missouri, and
Devault, Pennsylvania, and research and development and administrative offices
are located in El Segundo, California. In addition to our own production
facilities, we use co-manufacturers in various locations in the United States,
Canada and the Netherlands. In the second quarter of 2020, we acquired our first
manufacturing facility in Europe located in Enschede, the Netherlands. This
facility completed operational testing of dry blend production in late 2020 and
is expected to begin commercial trial runs in the second quarter of 2021. We
also announced the official opening of a new co-manufacturing facility, built by
our distributor in the Netherlands, to be used for Beyond Meat production. In
the third quarter of 2020, we and BYND JX entered into an investment agreement
and related factory leasing contract to design and develop manufacturing
facilities in the Jiaxing Economic & Technological Development Zone to
manufacture plant-based meat products under the Beyond Meat brand in China.
Renovations in the leased facility have been substantially completed and trial
production began in the first quarter of 2021. Full-scale end-to-end production
is expected by the end of the second quarter of 2021.
On January 15, 2021, we entered into a 12-year lease with two 5-year renewal
options to house our corporate headquarters, lab and innovation space in El
Segundo, California. See   Note 10  , Commitments and Contingencies, to the
Notes to Unaudited Condensed Consolidated Financial Statements included
elsewhere in this report.
On January 25, 2021, we entered into The PLANeT Partnership, LLC ("TPP"), a
joint venture with PepsiCo, Inc., to develop, produce and market innovative
snack and beverage products made from plant-
                                       31
--------------------------------------------------------------------------------

based protein. We believe TPP will allow us to reach more consumers by entering
new product categories and distribution channels, increasing accessibility to
plant-based protein around the world.
On March 5, 2021, we issued $1.0 billion aggregate principal amount of our 0%
Convertible Senior Notes due 2027 (the "Convertible Notes") in a private
placement to qualified institutional buyers pursuant to Rule 144A under the
Securities Act of 1933, as amended. On March 12, 2021, the initial purchasers of
the Convertible Notes exercised their option to purchase an additional $150.0
million aggregate principal amount of the Company's 0% Convertible Senior Notes
due 2027 (the "Additional Notes", and together with the Convertible Notes, the
"Notes"), and such Additional Notes were issued on March 16, 2021. The initial
conversion price of the Notes is $206.00, which represents a premium of
approximately 47.5% over the closing price of the Company's common stock on
March 2, 2021. The Notes will mature on March 15, 2027, unless earlier
repurchased, redeemed or converted. The Notes were issued pursuant to, and are
governed by, an indenture (the "Indenture"), dated as of March 5, 2021, between
us and U.S. Bank National Association, as trustee. We used $84.0 million of the
net proceeds from the sale of the Notes to fund the cost of entering into capped
call transactions, described below and intend to use the remainder of the net
proceeds for general corporate purposes and working capital. The proceeds from
the issuance of the Notes were approximately $1.0 billion, net of capped call
transactions cost of $84.0 million and debt issuance costs totaling
$23.6 million. See   Note 7  , Debt, to the Notes to Unaudited Condensed
Consolidated Financial Statements elsewhere in this report.
On March 2, 2021, in connection with the pricing of the offering of the
Convertible Notes, we entered into capped call transactions (the "Base Capped
Call Transactions") with the option counterparties and used $73.0 million in net
proceeds from the sale of the Convertible Notes to fund the cost of the Base
Capped Call Transactions. On March 12, 2021, in connection with the Additional
Notes, we entered into capped call transactions (the "Additional Capped Call
Transactions") with the option counterparties and used $11.0 million in net
proceeds from the sale of the Additional Notes to fund the cost of the
Additional Capped Call Transactions. The Base Capped Call Transactions and the
Additional Capped Call Transactions (collectively, the "Capped Call
Transactions") cover, subject to customary adjustments, the aggregate number of
shares of our common stock that will initially underlie the Notes, and are
expected generally to reduce potential dilution to our common stock upon any
conversion of Notes and/or offset any cash payments we are required to make in
excess of the principal amount of the converted Notes, as the case may be, with
such reduction and/or offset subject to a cap, based on the cap price of the
Capped Call Transactions. The cap price of the Capped Call Transactions is
$279.32, which represents a premium of 100% over the last reported sale price of
the Company's common stock on March 2, 2021. The aggregate $84.0 million paid
for the Capped Call Transactions was recorded as a reduction to APIC.
The condensed consolidated financial statements for the period ended April 3,
2021 include the accounts of the Company and its foreign subsidiaries, Beyond
Meat EU B.V. and BYND JX. All inter-company balances and transactions have been
eliminated.
We operate on a fiscal calendar year, and each interim quarter is comprised of
one 5-week period and two 4-week periods, with each week ending on a Saturday.
Our fiscal year always begins on January 1 and ends on December 31. As a result,
our first and fourth fiscal quarters may have more or fewer days included than a
traditional 91-day fiscal quarter.
Impact of COVID-19 on Our Business
The COVID-19 pandemic has had, and we expect will continue to have, certain
negative impacts on our business. COVID-19 has led governments and other
authorities around the world to implement significant measures intended to
control the spread of the virus, including social distancing measures, business
closures or restrictions on operations, quarantines and travel bans. While some
of these restrictions have been lifted or eased in many jurisdictions as the
rates of COVID-19 infections have decreased or stabilized, a resurgence of
COVID-19 and the discovery of various new COVID-19 variants in some markets has
slowed, halted or reversed the reopening process altogether.
In the fourth quarter of 2020, the FDA approved the distribution of various
COVID-19 vaccines for emergency use. Other COVID-19 vaccines have also been
approved for emergency use in other countries or
                                       32
--------------------------------------------------------------------------------

are pending approval in the U.S. While the rollout of the vaccines is currently
underway in the United States, we expect that it will take significant time
before the vaccines are widely available on a significant scale.
As government authorities around the world continue to implement significant
measures intended to control the spread of the virus and institute restrictions
on commercial operations, while at the same time rolling out vaccines and
implementing multi-step policies with the goal of re-opening certain markets, we
are working to ensure our compliance with these measures while also maintaining
business continuity for essential operations in our facilities. We have
established a cross-functional task force that meets regularly and continually
monitors and tracks relevant data, including guidance from local, national and
international health agencies. This task force works closely with our senior
leadership and is instrumental in making critical, timely decisions and is
committed to continuing to communicate to our employees as more information is
available to share.
While our manufacturing facilities remain operational, beginning in March 2020
employees at our corporate headquarters began working remotely. For essential
activities at our Manhattan Beach Project Innovation Center, we are strictly
limiting the number of employees allowed in the building and have implemented
physical distancing protocols, mandatory face coverings, temperature screening
of all personnel entering the site and comprehensive preventative hygienic
measures to support the health and safety of our employees. We expect our
corporate headquarters employees to remain working remotely pending further
notice and guidelines from local, state and federal agencies. At our
manufacturing facilities, we have implemented a series of physical distancing,
and hygienic practices to further support the health and safety of our
manufacturing employees. Our manufacturing employees are monitored for COVID-19
symptoms, including temperature screening of all personnel entering the site,
and are following strict COVID-19 suggested Personal Protective Equipment
guidelines per United States Centers for Disease Control and World Health
Organization, including mandatory face coverings, increased hand washing and
significantly increased sanitation of hard surfaces. All non-essential
company-sponsored travel has been suspended and field marketing activities have
been curbed due to the COVID-19-related restrictions.
For the first quarter of 2021, we generated foodservice channel net revenues of
$27.1 million compared to $41.2 million in the first quarter of 2020. Although
foodservice channel net revenues have been improving each successive quarter
after the decline in the second quarter of 2020, they have not recovered to the
level seen in the first quarter of 2020 and were 34.1% lower than the
foodservice channel net revenues in the first quarter of 2020. In response to
the recent COVID-19 resurgence in some markets, new lockdowns, curfews and other
restrictive measures are being imposed which have slowed, halted or reversed the
reopening process altogether and may adversely impact the foodservice recovery.
We continue to partner with our QSR and foodservice customers during this
challenging environment and during the quarter continued to offer promotional
programs to many of our foodservice partners to allow them to offer our products
to consumers at reduced price points or on other promotional terms. The impacts
of the ongoing COVID-19 pandemic also continue to result in delays in tests or
launches of our products among our foodservice customers and negatively impact
the rate of our growth. Excluding our sales to large QSR customers, our
foodservice channel has broad exposure to certain markets within that channel
that have been disproportionately affected by COVID-19. These include, among
others: amusement parks; academic institutions; hospitality; corporate catering
services; movie theaters; sports arenas; and bars and pubs. As such, we continue
to expect recovery in our foodservice channel net revenues to generally lag the
broader foodservice sector. While we saw some improvement in demand in our
foodservice business during the first quarter of 2021, amid relaxed stay-at-home
orders in some states, the environment remains highly uncertain given the
ongoing pandemic and COVID-19 resurgence. As a result, it is unclear how long it
will take for foodservice demand to return to pre-pandemic levels, if at all. We
expect revenues in our foodservice channel will continue to be significantly
negatively impacted through at least the remainder of 2021 and likely into 2022.
At the same time while foodservice channel net revenues declined, our retail
channel net revenues increased in the first quarter of 2021. For the first
quarter ended April 3, 2021, we generated retail channel net revenues of $81.0
million, representing an increase of 45% as compared to the first quarter of
2020 but a decrease of $18.6 million or 18.7% as compared to the second quarter
of 2020, when we experienced a retail surge amid panic buying in response to
COVID-19. The increase in our net revenues in the retail channel during the
first quarter of 2021, as compared to the prior-year period, was primarily
driven by our expansion in total retail outlets, higher sales velocity at
existing retail outlets and new product introductions. We also
                                       33
--------------------------------------------------------------------------------

continued to offer promotional and reduced pricing to certain of our retail
customers in the first quarter of 2021 to encourage greater consumer trial and
adoption of our products.
For the three months ended April 3, 2021, our retail and foodservice channels
accounted for approximately 74.9% and 25.1% of our net revenues, respectively.
For the three months ended March 28, 2020, our retail and foodservice channels
accounted for approximately 57.6% and 42.4% of our net revenues, respectively.
For the three months ended April 3, 2021, retail net revenues increased 45.0%,
while foodservice net revenues declined 34.1% compared to the prior-year period.
The change in mix of our distribution channels has been significant since the
start of the COVID-19 pandemic and is likely to continue to cause fluctuation in
our quarterly results depending on the duration, magnitude and effects of the
COVID-19 pandemic.
It is challenging to estimate the extent of the adverse impact of the COVID-19
pandemic on our results of operations, due to continued uncertainty regarding
the duration, magnitude and effects of the COVID-19 pandemic (including any
resurgences), impact of the new COVID-19 variants, rollout and uptake of the
COVID-19 vaccines and the public's willingness to receive them, potential supply
chain or manufacturing disruptions, and the magnitude of reduced customer
traffic at our foodservice customers, or the extent to which this reduction may
be offset by increased retail demand, or increasing consumer awareness of the
benefits of plant-based meat products. While the ultimate health and economic
impact of COVID-19 is highly uncertain, we expect that our business operations
and results of operations, including our net revenues, gross profit, gross
margin, earnings and cash flows, will be adversely impacted through 2021,
including as a result of:
•continued weak demand in the foodservice channel from decreased foot traffic in
foodservice establishments and the level of demand shift from foodservice to
retail business;
•increased cost of goods sold and increased promotional programs and trade
discounts to our retail and foodservice customers resulting in negative impacts
on our gross margins;
•potential disruption to the supply chain caused by distribution and other
logistical issues;
•potential disruption or closure of our facilities or those of our suppliers or
co-manufacturers due to employee contraction of COVID-19;
•the timing and success of strategic partnership launches and resumption of any
expansion plans for our product lines for those QSR customers who are in trial
or test phase;
•reduced consumer confidence and consumer spending (including as a result of
lower discretionary income due to unemployment or reduced or limited work as a
result of measures taken in response to the pandemic), including spending to
purchase our products; and negative trends in consumer purchasing patterns due
to consumers' disposable income, credit availability and debt levels;
•continued foodservice customer closures (including re-closures in connection
with resurgences of COVID-19) or further reduced operations;
•our ability to introduce new foodservice products as QSR and other partners
look to simplify menu offerings as a result of the pandemic;
•changes in the retail landscape, including the timing and level of trade and
promotion discounts, our ability to grow market share and increase household
penetration, repeat buying rates and purchase frequency, and our ability to
maintain and increase sales velocity of our products;
•the pace and success of new product introductions;
•the uncertain economic and political outlook in the U.S. and worldwide;
•uncertainty in the length of recovery time for the U.S. and world economies;
and
•disruptions in our ability to expand to new international locations.
Future events and effects related to COVID-19 cannot be determined with
precision and actual results could significantly differ from estimates or
forecasts.
                                       34
--------------------------------------------------------------------------------

Environmental, Social and Governance
As a disruptive leader in the food industry, the Company has established itself
as a leading producer of plant-based products that deliver a reduced
environmental footprint and mitigate the social and welfare issues inherent to
the production and consumption of animal protein. In order to continue that work
and position itself as a leader in the integration of environmental and social
change, the Company has committed to developing a comprehensive environmental,
social and governance ("ESG") program. As part of the development of its ESG
program, the Company has completed a materiality analysis and is working on
leveraging that analysis to create comprehensive ESG goals that will assist the
Company with its commitment to ensuring responsible and sustainable business
practices within its organization.
Components of Our Results of Operations and Trends and Other Factors Affecting
Our Business
Net Revenues
We generate net revenues primarily from sales of our products to our customers
across mainstream grocery, mass merchandiser, club, convenience store, and
natural retailer channels, direct-to-consumer, and various food-away-from-home
channels, including restaurants, foodservice outlets and schools, mainly in the
United States.
We present our net revenues by geography and distribution channel as follows:
Distribution Channel            Description
U.S. Retail                     Net revenues from retail sales to the U.S. market(1)
U.S. Foodservice                Net revenues from restaurant and foodservice sales to
                                the U.S. market
International Retail            Net revenues from retail sales to international markets,
                                including Canada
International Foodservice       Net revenues from restaurant and foodservice sales to
                                international markets, including Canada


___________

(1) Includes net revenues from direct-to-consumer sales.



The following factors and trends in our business have driven net revenue growth
over prior periods and are expected to be key drivers of our net revenue growth,
subject to the duration, magnitude and effects of COVID-19 as discussed above:
•increased penetration across our retail channel, including mainstream grocery,
mass merchandiser, club, convenience store, and natural retailer channels, and
our foodservice channel, including increased desire by foodservice
establishments, including large full service restaurants and/or global QSR
customers, to add plant-based products to their menus and to highlight these
offerings;
•the strength and breadth of our partnerships with global QSR restaurants and
retail and foodservice customers;
•distribution expansion, increased sales velocity, household penetration and
repeat buying rates across our channels;
•increased international sales of our products across geographies, markets and
channels as we continue to expand the breadth and depth of our international
distribution and grow our numbers of international customers;
•our continued innovation and product commercialization, including enhancing
existing products and introducing new products, such as Beyond Meatballs, Beyond
Breakfast Sausage Patties and Beyond Breakfast Sausage Links and the recent
launch of the latest iteration of our Beyond Burger, across our plant-based
platforms that appeal to a broad range of consumers, including those who
typically eat animal-based meat;
•enhanced marketing efforts as we continue to build our brand, amplify our value
proposition around taste, health and sustainability, serve as a best-in-class
partner to strategic and other QSR customers
                                       35
--------------------------------------------------------------------------------

to support product development and category management, and drive consumer
adoption of our products, including scaling our Go Beyond marketing campaign,
which seeks to mobilize our ambassadors to welcome consumers to the brand,
define the category and remain its leader, the launch of our What if We all Go
Beyond? brand anthem, inviting consumers to see how over time through small
changes, such as what you put at the center of your plate, there can be a
meaningful collective impact on human health and the health of our planet,
mobile pop-ups in select U.S. cities to give consumers an exclusive first taste
of our latest innovative products ahead of in-store availability, increased
social activity to build consumer awareness and excitement, shopper marketing
programs to incentive consumer trial, and a robust marketing campaign around the
launch of the latest iteration of our Beyond Burger;
•overall market trends, including growing consumer awareness and demand for
nutritious, convenient and high protein plant-based foods; and
•increased production levels as we invest in production infrastructure and scale
production to meet demand for our products across our distribution channels both
domestically and internationally.
In addition to the factors and trends above, we expect the following to
positively impact net revenues going forward, subject to the duration, magnitude
and effects of the COVID-19 pandemic:
•expansion of our own internal production facilities domestically and abroad to
produce our woven proteins, blends of flavor systems and binding systems, and
finished goods, while forming additional strategic relationships with
co-manufacturers; and
•localized production and third-party partnerships to increase the availability
and speed with which we can get our products to customers internationally.
We distribute our products internationally in more than 80 countries worldwide
as of April 3, 2021. In addition to our own production facilities, we use
co-manufacturers in various locations in the United States, Canada and the
Netherlands. International net revenues decreased 12.5% in the three months
ended April 3, 2021, as compared to the prior-year period, primarily due to the
decline in international foodservice net revenues attributable to COVID-19.
As we seek to continue to rapidly grow our net revenues, we face several
challenges. The extent of COVID-19's effect on our operational and financial
performance will depend on future developments, including the duration, spread
and intensity of COVID-19 (including any resurgences), impact of the new
COVID-19 variants and the rollout and uptake of COVID-19 vaccines, and the level
of social and economic restrictions imposed on the United States and abroad in
an effort to curb the spread of the virus, all of which are uncertain and
difficult to predict considering the rapidly evolving landscape. For example,
the impact of COVID-19 on any of our suppliers, co-manufacturers, distributors
or transportation or logistics providers may negatively affect the price and
availability of our ingredients and/or packaging materials and impact our supply
chain. Additionally, if we are forced to scale back hours of production or close
our production facilities or our Manhattan Beach Project Innovation Center in
response to the pandemic, we expect our business, financial condition and
results of operations would be materially adversely affected. In addition, our
growth strategy to expand our operations internationally may be impeded. We
expect to also continue to be impacted by decreased customer and consumer demand
as a result of event cancellations and social distancing, government-imposed
restrictions on public gatherings and businesses, shelter-in place orders and
temporary restaurant and retail store closures and operating restrictions. The
uncertainty created by COVID-19 significantly increases the difficulty in
forecasting operating results and strategic planning. As a result, it is not
currently possible to ascertain the overall impact of COVID-19 on our business,
results of operations, financial condition or liquidity. However, the pandemic
has had and may continue to have a material adverse impact on our business,
results of operations, financial condition and cash flows and may adversely
impact the trading price of our common stock. While the ultimate economic impact
of the COVID-19 pandemic is highly uncertain, we expect that the adverse impact
of COVID-19 pandemic on our business operations and results of operations,
including our net revenues, gross profit, gross margin, earnings and cash flows,
will continue through the remainder of 2021 and likely into 2022. Future events
and effects related to the COVID-19 pandemic cannot be determined with precision
and actual results could significantly differ from estimates or forecasts.
We routinely offer sales discounts and promotions through various programs to
customers and consumers. These programs include rebates, temporary on-shelf
price reductions, off-invoice discounts, retailer advertisements, product
coupons and other trade activities. We anticipate that we will need to continue
to offer
                                       36
--------------------------------------------------------------------------------

more trade and promotion discounts to both our retail and foodservice customers,
to drive increased consumer trial and in response to COVID-19. The expense
associated with these discounts and promotions is estimated and recorded as a
reduction in total gross revenues in order to arrive at reported net
revenues. At the end of each accounting period, we recognize a liability for
estimated sales discounts that have been incurred but not paid which totaled
$2.8 million and $3.6 million as of April 3, 2021 and December 31, 2020,
respectively. We anticipate that these promotional activities will impact our
net revenues as well as negatively impact our gross margins and profitability
and that changes in such activities will impact period-over-period results.
In addition, because we do not have any purchase commitments from our
distributors or customers, the amount of net revenues we recognize will vary
from period to period depending on the volume and the channels through which our
products are sold, causing variability in our results.
We expect to face increasing competition across all channels, especially as
additional plant-based protein product brands continue to enter the marketplace.
Gross Profit
Gross profit consists of our net revenues less cost of goods sold. Our cost of
goods sold primarily consists of the cost of raw materials and ingredients for
our products, direct labor and certain supply costs, co-manufacturing fees,
in-bound and internal shipping and handling costs incurred in manufacturing our
products, plant and equipment overhead, depreciation and amortization expense,
as well as the cost of packaging our products. In anticipation of future growth,
we have had to very quickly scale production and expand our sources of supply
for our core protein inputs such as pea protein.
We intend to continue to increase our production capabilities at our two
in-house manufacturing facilities in Columbia, Missouri, and Devault,
Pennsylvania, while expanding our co-manufacturing capacity and exploring
additional production facilities domestically and abroad. Our first
manufacturing facility in Europe is located in Enschede, the Netherlands. This
facility completed operational testing of dry blend production in late 2020 and
is expected to begin commercial trial runs in the second quarter of 2021. In
addition, in June 2020 we announced the official opening of a new
co-manufacturing facility, built by our distributor in the Netherlands, to be
used for Beyond Meat production. In the third quarter of 2020, we and BYND JX
entered into an investment agreement and related factory leasing contract to
design and develop manufacturing facilities to manufacture plant-based meat
products under the Beyond Meat brand in China. Renovations in the leased
facility have been substantially completed and trial production began in the
first quarter of 2021. Full-scale end-to-end production is expected by the end
of the second quarter of 2021. On October 30, 2020, we acquired certain assets
including land, building, manufacturing equipment and assembled workforce from
one of our former co-manufacturers located in Devault, Pennsylvania. We are
using this manufacturing facility for the production of our finished goods.
Acquisition of these assets is expected to allow us to reduce manufacturing and
packaging costs through vertical integration and provide opportunities for us to
test new processes and scale new products more quickly. As a result of these
expansion initiatives, we expect our cost of goods sold in absolute dollars to
increase to support our growth.
Subject to the ultimate duration, magnitude and effects of COVID-19, we continue
to expect that gross profit improvements will be delivered primarily through
improved volume leverage and throughput, greater internalization and geographic
localization of our manufacturing footprint and expansion of our own internal
production facilities domestically and abroad to produce our woven proteins,
blends of flavor systems and binding systems, and finished goods, materials and
packaging input cost reductions, tolling fee efficiencies, end-to-end production
processes across a greater proportion of our manufacturing network, scale-driven
efficiencies in procurement and fixed cost absorption, diversification of our
core protein ingredients, product and process innovations and reformulations,
cost-down initiatives through ingredient and process innovation and improved
supply chain logistics and distribution costs. We are also working to improve
gross margin through ingredient cost savings achieved through scale of
purchasing and through expanding our co-manufacturing network while negotiating
lower tolling fees. We intend to pass some of these cost savings on to the
consumer as we pursue our goal to achieve price parity with animal protein in at
least one of our product categories by 2024.
                                       37
--------------------------------------------------------------------------------

Margin improvement may, however, continue to be negatively impacted by our focus
on investing heavily in our business, establishing infrastructure in the U.S.,
EU and China, investing in personnel, partnerships and product pipeline,
investing in our headquarters campus and expanding our Manhattan Beach Project
Innovation Center, growing our customer base, volume deleveraging, aggressive
pricing strategies and increased discounting, expanding into new geographies and
markets, enhancing our production infrastructure, improving our innovation
capabilities, enhancing our product offerings and increasing consumer engagement
to apply increasing pressure on the three key levers of taste, health and cost
that we believe are critical for mass adoption.
Operating Expenses
Research and Development Expenses
Research and development expenses consist primarily of personnel and related
expenses for our research and development staff, including salaries, benefits,
bonuses, and share-based compensation, scale-up expenses, and depreciation and
amortization expense on research and development assets. Our research and
development efforts are focused on enhancements to our product formulations and
production processes in addition to the development of new products. We expect
to continue to invest substantial amounts in research and development, as
research and development and innovation are core elements of our business
strategy, and we believe they represent a critical competitive advantage for us.
We believe that we need to continue to rapidly innovate in order to continue to
capture a larger market share of consumers who typically eat animal-based meats.
Over time and subject to the duration, magnitude and effects of the COVID-19
pandemic, we expect these expenses to increase in absolute dollars, but to
decrease as a percentage of net revenues as we continue to scale production
volume.
SG&A Expenses
SG&A expenses consist primarily of selling, marketing and administrative
expenses, including personnel and related expenses, share-based compensation,
outbound shipping and handling costs, non-manufacturing lease expense,
depreciation and amortization expense on non-manufacturing assets and other
non-production operating expenses. Marketing and selling expenses include
share-based compensation awards to brand ambassadors, advertising costs, costs
associated with consumer promotions, product samples and sales aids incurred to
acquire new customers, retain existing customers and build our brand awareness.
Administrative expenses include the expenses related to management, accounting,
legal, IT, and other office functions.
We expect SG&A expenses in absolute dollars to increase as we increase our
domestic and international expansion efforts, expand our marketing efforts, and
incur costs related to our status as a public company.
We have historically had a very small sales and marketing force. As we continue
to grow, including internationally, we expect to expand our sales and marketing
force to address additional opportunities, which would substantially increase
our selling and marketing expense. Our administrative expenses are expected to
increase as a public company with increased personnel cost in accounting, legal,
IT and compliance-related functions.
Restructuring Expenses
In May 2017, management approved a plan to terminate an exclusive supply
agreement with one of our co-manufacturers. See   Note 3  , Restructuring, and
  Note 10  , Commitments and Contingencies, to the Notes to Unaudited Condensed
Consolidated Financial Statements, included elsewhere in this report.
Seasonality
Generally, we expect to experience greater demand for certain of our products
during the summer grilling season. In 2020, the impact of COVID-19 masked this
seasonal impact. As our business continues to grow, we expect to see additional
seasonality effects, especially within our retail channel, with revenue
contribution from this channel tending to be greater in the second and third
quarters of the year. In an environment of uncertainty from the impact of
COVID-19, we are unable to assess the ultimate impact on the demand for our
products as a result of seasonality.
                                       38
--------------------------------------------------------------------------------

Results of Operations The following table sets forth selected items in our condensed consolidated statements of operations for the periods presented:


                                                               Three Months Ended
                                                             April 3,       March 28,
        (in thousands)                                         2021           2020
        Net revenues                                       $  108,164      $  97,074
        Cost of goods sold                                     75,456         59,383
        Gross profit                                           32,708         37,691
        Research and development expenses                      15,925       

6,194


        Selling, general and administrative expenses           38,954       

27,315


        Restructuring expenses                                  2,474       

2,373


        Total operating expenses                               57,353       

35,882


        (Loss) income from operations                      $  (24,645)

$ 1,809




The following table presents selected items in our condensed consolidated
statements of operations as a percentage of net revenues for the periods
presented:
                                                               Three Months Ended
                                                            April 3,           March 28,
                                                              2021               2020
    Net revenues                                                  100.0  %       100.0  %
    Cost of goods sold                                             69.8           61.2
    Gross profit                                                   30.2           38.8
    Research and development expenses                              14.7            6.4
    Selling, general and administrative expenses                   36.0           28.1
    Restructuring expenses                                          2.3            2.4
    Total operating expenses                                       53.0           37.0
    (Loss) income from operations                                 (22.8) %         1.9  %



Three Months Ended April 3, 2021 Compared to Three Months Ended March 28, 2020
(unaudited)
Net Revenues
Net revenues increased by $11.1 million, or 11.4%, in the three months ended
April 3, 2021, as compared to the prior-year period primarily due to an increase
in volume sold, partially offset by lower net price per pound driven by our
strategic investments in promotional activity intended to encourage greater
consumer trial and adoption and, to a lesser extent, product mix shifts as
larger-pack items carrying a lower net price per unit volume accounted for a
greater proportion of our retail net revenues compared to the prior-year period.
Growth in net revenues was primarily due to increased retail channel sales,
resulting from retail distribution gains, higher sales velocities at existing
retail customers, and contribution from new product introductions. The increase
in retail channel sales was largely offset by a decline in foodservice channel
sales as a result of the continued impact of COVID-19 on foodservice demand
levels.
                                       39
--------------------------------------------------------------------------------

The following table presents our net revenues by channel in the three months ended April 3, 2021 as compared to the prior-year period:


                                               Three Months Ended                 Change
                                             April 3,       March 28,
         (in thousands)                        2021           2020          Amount          %
         U.S.:
         Retail                            $   63,826      $  49,923      $ 13,903        27.8  %
         Foodservice                           16,742         22,631        (5,889)      (26.0) %
         U.S. net revenues                     80,568         72,554         8,014        11.0  %
         International:
         Retail                                17,199          5,952        11,247       189.0  %
         Foodservice                           10,397         18,568        (8,171)      (44.0) %
         International net revenues            27,596         24,520         3,076        12.5  %

         Net revenues                      $  108,164      $  97,074      $ 11,090        11.4  %



Net revenues from U.S. retail sales in the three months ended April 3, 2021
increased $13.9 million, or 27.8%, primarily due to increases in sales of Beyond
Breakfast Sausage, Beyond Meatball, Beyond Sausage and Beyond Beef.
Approximately 33% of the increase in U.S. retail sales was due to the
introduction of Beyond Meatball during the third quarter of 2020 and Beyond
Breakfast Sausage Links during the second quarter of 2020.
Net revenues from U.S. foodservice sales in the three months ended April 3, 2021
decreased $5.9 million, or 26.0%, primarily due to decreases in sales of all
product categories, principally due to the impact of COVID-19 on our foodservice
customers. Our products were available at approximately 32,000 U.S. retail
outlets and 39,000 U.S. foodservice outlets as of April 3, 2021.
Net revenues from international retail sales in the three months ended April 3,
2021 increased $11.2 million, or 189.0%, primarily due to the increase in sales
of Beyond Burger, Beyond Sausage and Beyond Beef. Our products were available at
approximately 24,000 international retail outlets as of April 3, 2021.
International retail outlets where our products are distributed declined in the
three month ended April 3, 2021 from the number of outlets as of December 31,
2020 due to a recent transition away from our former distribution partner in
Germany who relied heavily on discounting and limited-time placements at various
retail outlets.
Net revenues from international foodservice sales in the three months ended
April 3, 2021 decreased $8.2 million, or 44.0%, primarily due to the impact of
COVID-19 on our foodservice customers. Our products were available at
approximately 23,000 international foodservice outlets as of April 3, 2021.
The following table presents consolidated volume of our products sold in pounds
for the periods presented:
                                             Three Months Ended                    Change
                                       April 3,             March 28,
        (in thousands)                   2021                  2020         Amount          %

        U.S.:
        Retail                         11,128                8,446           2,682        31.8  %
        Foodservice                     2,882                4,066          (1,184)      (29.1) %
        International:
        Retail                          2,959                  828           2,131       257.4  %
        Foodservice                     2,003                3,312          (1,309)      (39.5) %
        Volume of products sold        18,972               16,652          

2,320 13.9 %


                                       40
--------------------------------------------------------------------------------

Cost of Goods Sold
                                          Three Months Ended                 Change
                                        April 3,       March 28,
              (in thousands)              2021           2020          Amount          %
              Cost of goods sold      $   75,456      $  59,383      $ 16,073        27.1  %



Cost of goods sold increased by $16.1 million, or 27.1%, to $75.5 million, in
the three months ended April 3, 2021 as compared to the prior-year period. Cost
of goods sold in the three months ended April 3, 2021 increased to 69.8% from
61.2% of net revenues in the prior-year period. The increase in cost of goods
sold was primarily due to an increase in the volume of products sold, higher
warehousing costs, higher depreciation and amortization expense, and higher
in-bound and internal shipping and handling costs.
Gross Profit and Gross Margin
                                      Three Months Ended                     Change
                                 April 3,            March 28,
           (in thousands)          2021                2020          Amount              %
           Gross profit          $32,708              $37,691       $(4,983)          (13.2)%
           Gross margin           30.2%                38.8%        (860) bps           N/A



Gross profit in the three months ended April 3, 2021 was $32.7 million as
compared to gross profit of $37.7 million in the prior-year period, a decline of
$5.0 million. Gross margin in the three months ended April 3, 2021 declined to
30.2% from 38.8% in the prior-year period. The decline in gross profit and gross
margin in the three months ended April 3, 2021 was primarily due to higher
inbound and internal shipping and handling costs driven by higher lane rates, an
increase in warehousing costs driven by higher inventory levels particularly for
pea protein, lower net price realization as a result of higher trade discounts
and product mix shifts, higher depreciation and amortization expense primarily
attributable to incremental fixed assets associated with the Company's
production facilities in Pennsylvania, the Netherlands and China, and increased
fixed overhead costs due to the Company's recent acquisition of a former
co-manufacturing partner and increase in assets in the Company's international
subsidiaries. As disclosed in   Note 2  , Summary of Significant Accounting
Policies-Shipping and Handling Costs, in the Notes to Unaudited Condensed
Consolidated Financial Statements included elsewhere in this report, we include
outbound shipping and handling costs within SG&A expenses. As a result, our
gross profit and gross margin may not be comparable to other entities that
present shipping and handling costs as a component of cost of goods sold.
Research and Development Expenses
                                                  Three Months Ended                  Change
                                               April 3,        March 28,
      (in thousands)                             2021             2020         Amount          %
      Research and development expenses      $    15,925      $    6,194      $ 9,731       157.1  %



Research and development expenses increased $9.7 million, or 157.1%, in the
three months ended April 3, 2021, as compared to the prior-year period. Research
and development expenses increased to 14.7% of net revenues in the three months
ended April 3, 2021 from 6.4% of net revenues in the prior-year period primarily
due to a 59% increase in headcount, higher scale-up expenses and higher
depreciation and amortization expense compared to the prior-year period.
                                       41
--------------------------------------------------------------------------------


SG&A Expenses
                                                       Three Months Ended                 Change
                                                     April 3,       March 28,
(in thousands)                                         2021           2020 

Amount % Selling, general and administrative expenses $ 38,954 $ 27,315 $ 11,639 42.6 %





SG&A expenses increased $11.6 million, or 42.6%, in the three months ended
April 3, 2021 to 36.0% of net revenues in the three months ended April 3, 2021,
from 28.1% of net revenues in the prior-year period. The increase in SG&A
expenses was primarily due to $8.5 million in higher salaries and related
expenses resulting from higher headcount, $1.8 million in higher share-based
compensation expense, $1.7 million in higher outbound freight costs and $0.9
million in higher general insurance costs, partially offset by $1.1 million in
lower product donations and $0.6 million in lower legal fees. The increase in
share-based compensation expense in the three months ended April 3, 2021 was
primarily due to substantially higher staffing levels and to a lesser extent due
to the appreciation in our stock price as compared to the prior-year period.
Restructuring Expenses
As a result of the termination in May 2017 of an exclusive supply agreement with
one of our co- manufacturers due to non-performance under the agreement, we
recorded restructuring expenses of $2.5 million and $2.4 million in the three
months ended April 3, 2021 and March 28, 2020, respectively. The restructuring
expenses were primarily related to legal and other expenses associated with the
dispute. As of April 3, 2021 and December 31, 2020, there were $2.4 million and
$0.8 million, respectively, in accrued and unpaid restructuring expenses. We
continue to incur legal fees and other costs in connection with our ongoing
efforts to resolve this dispute. See   Note 3  , Restructuring, and   Note 10  ,
Commitments and Contingencies to the Notes to Unaudited Condensed Consolidated
Financial Statements included elsewhere in this report.
(Loss) Income from Operations
Loss from operations in the three months ended April 3, 2021 was $24.6 million
compared to income from operations of $1.8 million in the prior-year period. The
decrease in income from operations in the three months ended April 3, 2021 was
primarily driven by lower gross profit, growth in overall headcount levels
primarily to support increased innovation capabilities and international growth,
increased production trial activities, higher share-based compensation expense
and higher freight costs included in our selling expenses compared to the
prior-year period.
Total Other Expense (Income)
Total other expense, net in the three months ended April 3, 2021 of $2.2 million
consisted primarily of $1.0 million in costs associated with early
extinguishment of our revolving credit facility, $0.6 million in interest
expense on our bank debt including $0.3 million in amortization of debt issuance
costs and foreign currency transaction losses of $0.3 million. Total other
income of $5,000 in the prior-year period primarily included interest income,
partially offset by $0.7 million in interest expense on our debt balances.
Net Loss
Net loss was $27.3 million in the three ended April 3, 2021, respectively,
compared to net income of $1.8 million in the prior-year period. Net loss during
the three months ended April 3, 2021 was primarily due to lower gross profit and
higher operating expenses discussed above compared to the prior-year period.

                                       42
--------------------------------------------------------------------------------

Non-GAAP Financial Measures
We use the non-GAAP financial measures set forth below in assessing our
operating performance and in our financial communications. Management believes
these non-GAAP financial measures provide useful additional information to
investors about current trends in our operations and are useful for
period-over-period comparisons of operations. In addition, management uses these
non-GAAP financial measures to assess operating performance and for business
planning purposes. Management also believes these measures are widely used by
investors, securities analysts, rating agencies and other parties in evaluating
companies in our industry as a measure of our operational performance. These
non-GAAP financial measures should not be considered in isolation or as a
substitute for the comparable GAAP measures. In addition, these non-GAAP
financial measures may not be computed in the same manner as similarly titled
measures used by other companies.
"Adjusted EBITDA" is defined as net (loss) income adjusted to exclude, when
applicable, income tax expense (benefit), interest expense, depreciation and
amortization expense, restructuring expenses, share-based compensation expense,
expenses attributable to COVID-19, remeasurement of our warrant liability, and
Other, net, including interest income, loss on extinguishment of debt and
foreign currency transaction gains and losses.
"Adjusted EBITDA as a % of net revenues" is defined as Adjusted EBITDA divided
by net revenues.
There are a number of limitations related to the use of Adjusted EBITDA and
Adjusted EBITDA as a % of net revenues rather than their most directly
comparable GAAP measure. Some of these limitations are:
•Adjusted EBITDA excludes depreciation and amortization expense and, although
these are non-cash expenses, the assets being depreciated may have to be
replaced in the future increasing our cash requirements;
•Adjusted EBITDA does not reflect interest expense, or the cash required to
service our debt, which reduces cash available to us;
•Adjusted EBITDA does not reflect income tax payments that reduce cash available
to us;
•Adjusted EBITDA does not reflect restructuring expenses that reduce cash
available to us;
•Adjusted EBITDA does not reflect expenses attributable to COVID-19 that reduce
cash available to us;
•Adjusted EBITDA does not reflect share-based compensation expense and therefore
does not include all of our compensation costs;
•Adjusted EBITDA does not reflect Other, net, including loss on extinguishment
of debt and foreign currency transaction gains and losses, that may increase or
decrease cash available to us; and
•other companies, including companies in our industry, may calculate Adjusted
EBITDA differently, which reduces its usefulness as a comparative measure.
                                       43
--------------------------------------------------------------------------------

The following table presents the reconciliation of Adjusted EBITDA to its most comparable GAAP measure, net (loss) income, as reported (unaudited):


                                                  Three Months Ended
                                                April 3,       March 28,
(in thousands)                                    2021           2020
Net (loss) income, as reported                $ (27,266)      $  1,815
Income tax expense (benefit)                         48             (1)
Interest expense                                    629            705
Depreciation and amortization expense             4,326          2,583
Restructuring expenses(1)                         2,474          2,373
Share-based compensation expense                  7,376          5,949
Expenses attributable to COVID-19(2)                  -          1,175

Other, net(3)                                     1,570           (710)
Adjusted EBITDA                               $ (10,843)      $ 13,889

Net (loss) income as a % of net revenues (25.2) % 1.9 % Adjusted EBITDA as a % of net revenues

            (10.0) %        14.3  %


____________

(1) Primarily comprised of legal and other expenses associated with the dispute with a

co-manufacturer with whom an exclusive supply agreement was terminated in May 2017. (2) Expenses attributable to COVID-19 in the three months ended March 28, 2020 include

$1.2 million in product donation costs related to our COVID-19 relief campaign. (3) Includes $1.0 million in loss on extinguishment of debt in the three months ended

April 3, 2021.



Liquidity and Capital Resources
Convertible Senior Notes
On March 5, 2021, we issued $1.0 billion aggregate principal amount of our 0%
Convertible Senior Notes due 2027 (the "Convertible Notes") in a private
placement to qualified institutional buyers pursuant to Rule 144A under the
Securities Act of 1933, as amended. On March 12, 2021, the initial purchasers of
the Convertible Notes exercised their option to purchase an additional $150.0
million aggregate principal amount of the Company's 0% Convertible Senior Notes
due 2027 (the "Additional Notes" and, together with the Convertible Notes, the
"Notes"), and such Additional Notes were issued on March 16, 2021. The initial
conversion price of the Notes is $206.00, which represents a premium of
approximately 47.5% over the closing price of our common stock on March 2, 2021.
The Notes will mature on March 15, 2027, unless earlier repurchased, redeemed or
converted. The Notes were issued pursuant to, and are governed by, an indenture
(the "Indenture"), dated as of March 5, 2021, between the Company and U.S. Bank
National Association, as trustee. We used $84.0 million of the net proceeds from
the sale of the Notes to fund the cost of entering into capped call
transactions. The net proceeds from the issuance of the Notes were approximately
$1.0 billion, net of capped call transaction costs of $84.0 million and debt
issuance costs totaling $23.6 million. See   Note 7  , Debt, to the Notes to
Unaudited Condensed Consolidated Financial Statements included elsewhere in this
report.
Revolving Credit Facility
On March 2, 2021, we terminated our secured revolving credit agreement, dated as
of April 21, 2020 (the "Credit Agreement"), among the Company, as borrower, the
lenders party thereto and JPMorgan Chase Bank, N.A., as the administrative
agent, and in connection with such termination: (i) all borrowings outstanding
under the Credit Agreement were repaid in full by the Company; and (ii) all
liens and security interests under the Credit Agreement in favor of the lenders
thereunder were released. See   Note 7  , Debt, to the Notes to Unaudited
Condensed Consolidated Financial Statements included elsewhere in this report.
                                       44
--------------------------------------------------------------------------------

Liquidity


Our primary cash needs are for operating expenses, working capital and capital
expenditures to support the growth in our business.
In March 2021, we issued $1,150.0 million in aggregate principal amount of Notes
as discussed above.
As of April 3, 2021, we had $1,125.0 million in cash and cash equivalents. We
believe that our cash and cash equivalents and cash flow from operating
activities will be sufficient to fund our working capital and meet our
anticipated capital requirements for the next 12 months. Additionally, we may
also raise funds by issuing debt or equity securities. Our future capital
requirements may vary materially from those currently planned and will depend on
many factors, including the impact of the COVID-19 global pandemic; the number
and characteristics of any additional products or manufacturing processes we
develop or acquire to serve new or existing markets; our investment in and build
out of our campus headquarters; the expenses associated with our marketing
initiatives; our investment in manufacturing and facilities to expand our
manufacturing and production capacity; the costs required to fund domestic and
international growth; the scope, progress, results and costs of researching and
developing future products or improvements to existing products or manufacturing
processes; any lawsuits related to our products or commenced against us,
including the costs associated with our current litigation with a former
co-manufacturer, the putative class action cases brought against us, and the
shareholder derivative lawsuits putatively brought on our behalf; the expenses
needed to attract and retain skilled personnel; the costs associated with being
a public company; the costs involved in preparing, filing, prosecuting,
maintaining, defending and enforcing intellectual property claims, including
litigation costs and the outcome of such litigation; and the timing, receipt and
amount of sales of, or royalties on, any future approved products, if any.
Cash Flows
In the three months ended April 3, 2021, approximately $48.1 million in
aggregate expenditures to purchase inventory and property, plant and equipment
and approximately $3.9 million in other cash outflows from operating, investing
and financing activities were funded by net borrowings, after repaying the
entire balance of the revolving credit facility, of $1,017.9 million.
The following table presents the major components of net cash flows used in and
provided by operating, investing and financing activities for the periods
indicated.
                                      Three Months Ended
                                   April 3,        March 28,
(in thousands)                       2021            2020
Cash (used in) provided by:
Operating activities             $   (30,657)     $ (17,202)
Investing activities             $   (23,381)     $ (13,362)
Financing activities             $ 1,019,913      $     986


Net Cash Used in Operating Activities
In the three months ended April 3, 2021, we incurred a net loss of $27.3 million
which was the primary reason for net cash used in operating activities of $30.7
million. Net cash outflows from changes in our operating assets and liabilities
was $17.6 million, primarily due to the increase in finished goods inventory.
The cash outflows from an increase in inventory was partially offset by the
increase in accrued expenses and other current liabilities. Net loss in the
three months ended April 3, 2021 included $14.2 million in non-cash expenses
primarily comprised of share-based compensation expense and depreciation and
amortization expense.
In the three months ended March 28, 2020, we recorded net income of $1.8
million. The primary reason for net cash used in operating activities of $17.2
million was $28.1 million in net cash outflows from changes in our operating
assets and liabilities, primarily due to increase in inventory to meet growth in
anticipated sales and to accommodate longer lead times for international
shipments and prepayments to one of our pea protein suppliers, partially offset
by the increase in accounts payable. Net income in the three months ended March
28,
                                       45
--------------------------------------------------------------------------------

2020 included $9.0 million in non-cash expenses primarily comprised of
depreciation and amortization expense and share-based compensation expense.
Depreciation and amortization expense was $4.3 million and $2.6 million in the
three months ended April 3, 2021 and March 28, 2020, respectively.
Net Cash Used in Investing Activities
Net cash used in investing activities primarily relates to capital expenditures
to support our growth and investment in property, plant and equipment.
In the three months ended April 3, 2021, net cash used in investing activities
was $23.4 million and consisted of cash outflows for purchases of property,
plant and equipment, primarily driven by continued investments in production
equipment and facilities related to our capacity expansion initiatives and
international expansion.
In the three months ended March 28, 2020, net cash used in investing activities
was $13.4 million and consisted of $12.4 million in cash outflows for purchases
of property, plant and equipment, primarily driven by growth in capital
production equipment purchases related to our capacity expansion initiatives and
$1.0 million in cash outflows related to property, plant and equipment purchased
for sale to co-manufacturers.
Net Cash Provided by Financing Activities
In the three months ended April 3, 2021, net cash provided by financing
activities was $1,019.9 million primarily from the proceeds of the Notes of
$1,066.1 million and $2.9 million in proceeds from stock option exercises,
partially offset by repayment of revolving credit facility of $25.0 million,
debt issuance costs of $23.2 million associated with the Notes and $0.8 million
in payments of minimum withholding taxes on net share settlement of equity
awards, and payments under finance lease obligations.
In the three months ended March 28, 2020, net cash provided by financing
activities was $1.0 million primarily from proceeds from stock option exercises.
As of March 28, 2020, we had borrowed the entire availability of $20.0 million
under the term loan facility and $6.0 million under the revolving credit
facility provided by Silicon Valley Bank. Both facilities were terminated on
April 21, 2020.
Contractual Obligations and Commitments
There have been no significant changes during the three months ended April 3,
2021 to the contractual obligations disclosed in Management's Discussion and
Analysis of Financial Condition and Results of Operations set forth in the 2020
10-K, other than the following:
Convertible Senior Notes
On March 5, 2021, we issued $1.0 billion aggregate principal amount of
Convertible Notes and on March 16, 2021, we issued $150.0 million aggregate
principal amount of Additional Notes. The proceeds from the issuance of the
Notes were approximately $1.0 billion, net of capped call transaction costs of
$84.0 million and debt issuance costs totaling $23.6 million. See   Note
7  , Debt, to the Notes to Unaudited Condensed Consolidated Financial Statements
included elsewhere in this report.
Leases
On January 14, 2021, we entered into a Lease (the "Campus Lease") with HC Hornet
Way, LLC, a Delaware limited liability company (the "Landlord"), to house our
headquarters offices, lab and innovation space in El Segundo, California. The
initial term of the Campus Lease is 12 years, with two renewal options, each for
a period of five years.
Under the terms of the Campus Lease, we will lease an aggregate of approximately
281,110 rentable square feet in a portion of a building located at 888 Douglas
Street, El Segundo, California (the "Premises"), to be built out by Landlord and
delivered to the Company in three phases over a 26 month period. Aggregate
payments towards base rent for the Premises over the term of the lease will be
approximately $159.3 million.
                                       46
--------------------------------------------------------------------------------

We are involved in the design of the Premises during the construction phase
incurring the cost of certain architectural services and design elements, and
consider these as costs of tenant improvements to the Premises we expect to
ultimately lease pursuant to the terms of the Campus Lease. The Landlord is
providing a tenant improvement allowance equal to $100.00 per rentable square
foot for each phase of the Premises (the "Tenant Improvement Allowance") to be
used towards the cost of the build-out of the Premises, with the Company
responsible for any build-out costs in excess of the Tenant Improvement
Allowance. Neither we nor the Landlord intend or expect that the costs of tenant
improvements will be consideration paid to the Landlord for the right to use the
Premises that would reduce the amount of future cash lease payments required
after we take possession of the Premises. We will recognize the lease assets and
liabilities for each phase when the Landlord makes the underlying asset for each
phase available to us. During the construction phase, we are expected to have
access to the Premises to start to construct tenant improvements on the Base,
Shell and Core ("BSC") Completion Date, the date on which the Landlord is
expected to make the Premises available to us to construct such tenant
improvements. As of April 3, 2021, the BSC Completion Date had not yet occurred
or been communicated to us. Therefore, we have not recognized an asset or a
liability for the Campus Lease in our condensed consolidated balance sheet as of
April 3, 2021.
Concurrent with the Company's execution of the Lease, as a security deposit, we
delivered to Landlord a letter of credit in the amount of $12.5 million which
amount will decrease to: (i) $6.3 million on the fifth (5th) anniversary of the
Rent Commencement Date; (ii) $3.1 million on the eighth (8th) anniversary of the
Rent Commencement Date; and (iii) $0 in the event the Company receives certain
credit ratings; provided the Company is not then in default of its obligations
under the Lease. Upon termination of the revolving credit facility, the letter
of credit continued in effect, unsecured.
China Investment and Lease Agreement
On September 22, 2020, we and BYND JX entered into an investment agreement with
the Administrative Committee (the "JX Committee") of the Jiaxing Economic &
Technological Development Zone (the "JXEDZ") pursuant to which, among other
things, BYND JX has agreed to make certain investments in the JXEDZ in two
phases of development and we have agreed to guarantee certain repayment
obligations of BYND JX under such agreement. See   Note 2  , Summary of
Significant Accounting Policies, elsewhere in this report.

During Phase 1, the Company has agreed to invest $10.0 million in the JXEDZ
through an intercompany investment in BYND JX and BYND JX has agreed to lease a
facility in the JXEDZ for a minimum of two (2) years. In connection with such
agreement, BYND JX entered into a factory leasing contract as of September 10,
2020 with an affiliate of the JX Committee, pursuant to which BYND JX has agreed
to lease and renovate a facility in the JXEDZ and lease it for a minimum of two
(2) years. As of April 3, 2021, renovations in the leased facility have been
substantially completed, with trial production completed in the first quarter of
2021. Full-scale end-to-end production is expected by the end of the second
quarter of 2021. In the event that the Company and BYND JX determine, in their
sole discretion, to proceed with the Phase 2 development in the JXEDZ, BYND JX
has agreed in the first stage of Phase 2 to increase its registered capital by
$30.0 million and to acquire the land use right to a state-owned land plot in
the JXEDZ to conduct development and construction of a new production facility.
Following the first stage of Phase 2, the Company and BYND JX may determine, in
their sole discretion, to permit BYND JX to obtain a second state-owned land
plot in the JXEDZ in order to construct an additional facility thereon. See
  Note 10  , Commitments and Contingencies, to the Notes to Unaudited Condensed
Consolidated Financial Statements included elsewhere in this report.
Investment in The PLANeT Partnership
On January 25, 2021, the Company entered into The PLANeT Partnership, LLC
("TPP"), a joint venture with PepsiCo, Inc., to develop, produce and market
innovative snack and beverage products made from plant-based protein. The
Company believes TPP will allow the Company to reach more consumers by entering
new product categories and distribution channels, increasing accessibility to
plant-based protein around the world. For the three months ended April 3, 2021,
the Company recognized its share of the net losses in TPP in the amount of $0.4
million. No such amounts were recognized in the three months ended March 28,
2020.
                                       47
--------------------------------------------------------------------------------

Purchase Commitments
As of April 3, 2021, we had a commitment to purchase pea protein inventory
totaling $141.9 million, approximately $83.4 million in the remainder of 2021
and $58.5 million in 2022. In addition, as of April 3, 2021, we had
approximately $21.7 million in purchase order commitments for capital
expenditures primarily to purchase machinery and equipment. Payments for these
purchases will be due within twelve months. We intend to use cash from
operations to fund these purchase commitments.
Off-balance Sheet Arrangements
We do not have any off-balance sheet arrangements or any holdings in variable
interest entities.
Critical Accounting Policies
In preparing our financial statements in accordance with GAAP, we are required
to make estimates and assumptions that affect the amounts of assets,
liabilities, revenue, costs and expenses, and disclosure of contingent assets
and liabilities that are reported in the financial statements and accompanying
disclosures. We evaluate our estimates and assumptions on an ongoing basis. Our
estimates are based on historical experience and various other assumptions that
we believe to be reasonable under the circumstances. Our actual results may
differ from these estimates and assumptions. To the extent that there are
differences between our estimates and actual results, our future financial
statement presentation, financial condition, results of operations and cash
flows will be affected.
There have been no material changes in our critical accounting policies during
the three months ended April 3, 2021, as compared to those disclosed in
the "Management's Discussion and Analysis of Financial Condition and Results of
Operations-Critical Accounting Policies" in the 2020 10-K other than as
described in   Note 2  , Summary of Significant Accounting Policies, to the
Notes to Unaudited Condensed Consolidated Financial Statements included
elsewhere in this report.
Emerging Growth Company Status
Effective December 31, 2020, we lost our EGC status and are now categorized as a
Large Accelerated Filer based upon the current market capitalization of the
Company according to Rule 12b-2 of the Exchange Act. As a result, we must comply
with all financial disclosure and governance requirements applicable to Large
Accelerated Filers.
Recent Accounting Pronouncements
Please refer to   Note 2  , Summary of Significant Accounting Policies, to the
Notes to Unaudited Condensed Consolidated Financial Statements included
elsewhere in this report for a discussion of recently adopted accounting
pronouncements and new accounting pronouncements that may impact us.

                                       48

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses